Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) was upgraded by Sanford C. Bernstein from a "hold" rating to a "strong-buy" rating in a note issued to investors on Thursday,Zacks.com reports.
Separately, Royal Bank of Canada reaffirmed an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and four have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy".
Read Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 0.2%
Reckitt Benckiser Group stock traded down $0.03 during midday trading on Thursday, reaching $13.89. The stock had a trading volume of 536,230 shares, compared to its average volume of 388,482. Reckitt Benckiser Group has a 12 month low of $10.43 and a 12 month high of $14.10. The company has a fifty day moving average price of $13.08 and a two-hundred day moving average price of $12.87. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
